Millennium Management’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-23,373
| Closed | -$29.9K | – | 4216 |
|
|
2024
Q2 | $29.9K | Sell |
23,373
-21,043
| -47% | -$26.9K | ﹤0.01% | 3820 |
|
|
2024
Q1 | $167K | Buy |
44,416
+31,652
| +248% | +$119K | ﹤0.01% | 3711 |
|
|
2023
Q4 | $41.7K | Buy |
+12,764
| New | +$41.7K | ﹤0.01% | 3823 |
|
|
2023
Q3 | – | Sell |
-12,562
| Closed | -$56.3K | – | 4301 |
|
|
2023
Q2 | $56.3K | Buy |
+12,562
| New | +$56.3K | ﹤0.01% | 3948 |
|
|
2022
Q2 | – | Sell |
-10,808
| Closed | -$44K | – | 5238 |
|
|
2022
Q1 | $44K | Sell |
10,808
-4,946
| -31% | -$20.1K | ﹤0.01% | 4971 |
|
|
2021
Q4 | $84K | Buy |
+15,754
| New | +$84K | ﹤0.01% | 4904 |
|
|
2021
Q3 | – | Sell |
-23,878
| Closed | -$239K | – | 5231 |
|
|
2021
Q2 | $239K | Buy |
23,878
+9,511
| +66% | +$95.2K | ﹤0.01% | 4628 |
|
|
2021
Q1 | $214K | Buy |
+14,367
| New | +$214K | ﹤0.01% | 4122 |
|